Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The anabolic role of the Warburg, Cori-cycle and Crabtree effects in health and disease.

Clinical nutrition (Edinburgh, Scotland)·2021
Same author

The role of ectopic adipose tissue: benefit or deleterious overflow?

European journal of clinical nutrition·2020
Same author

A serendipitous voyage in the field of nutrition and metabolism in health and disease: a translational adventure.

European journal of clinical nutrition·2020
Same author

Editorial: Vegan diets: what is the benefit?

Current opinion in clinical nutrition and metabolic care·2020
Same author

Editorial: Ketogenic diets: what is the benefit?

Current opinion in clinical nutrition and metabolic care·2019
Same author

Hypoalbuminemia: Pathogenesis and Clinical Significance.

JPEN. Journal of parenteral and enteral nutrition·2018
Same journal

The updated recommendations for medical nutrition in the perioperative period: a focus on early oral intake.

Current opinion in clinical nutrition and metabolic care·2026
Same journal

Pediatric and adolescent nutritional and metabolic assessment in the precision era.

Current opinion in clinical nutrition and metabolic care·2026
Same journal

Nutrition in cirrhosis: bridging guidelines and practice in hepatic disease.

Current opinion in clinical nutrition and metabolic care·2026
Same journal

Metabolic health in a changing world: widening the lens to climate, cities, and place.

Current opinion in clinical nutrition and metabolic care·2026
Same journal

Beyond the scale: a systems-level reframing of obesity and metabolic care.

Current opinion in clinical nutrition and metabolic care·2026
Same journal

Editorial: Metabolic plasticity and the path to clinical utility.

Current opinion in clinical nutrition and metabolic care·2026
See all related articles

Related Experiment Videos

Rationale for albumin infusions.

Peter B Soeters1

  • 1Department of Surgery, Maastricht University Medical Center, The Netherlands. PB.Soeters@ah.unimaas.nl

Current Opinion in Clinical Nutrition and Metabolic Care
|April 2, 2009
PubMed
Summary
This summary is machine-generated.

Albumin infusion does not improve clinical outcomes in most diseases, despite its roles as a binding and oncotic agent. Freshly synthesized, non-oxidized albumin may offer future clinical benefits.

Related Experiment Videos

Area of Science:

  • Biochemistry
  • Physiology
  • Clinical Medicine

Background:

  • Albumin is a key protein in plasma, serving critical roles in binding, oncotic pressure, and scavenging.
  • Disease states can accelerate albumin degradation and compromise its function due to oxidation.
  • Understanding albumin's metabolism is crucial for evaluating its therapeutic potential.

Purpose of the Study:

  • To elucidate the metabolism and function of albumin.
  • To critically assess the evidence supporting albumin infusion benefits in various diseases.
  • To explain the limited clinical efficacy of albumin infusion in most studied conditions.

Main Methods:

  • Literature review and critical analysis of existing studies on albumin metabolism and infusion therapy.
  • Examination of albumin's biochemical properties and its behavior in physiological and pathological conditions.
  • Comparison of clinical outcomes from albumin infusion versus other fluid therapies.

Main Results:

  • Albumin functions as a binding protein, oncotic agent, and extracellular scavenger, but oxidation compromises its integrity and accelerates degradation, especially in disease.
  • Albumin infusion fails to improve clinical outcomes in chronic diseases and is not superior to alternatives in acute hypovolemia, with exceptions like liver failure.
  • Pharmaceutical albumin may lack the beneficial oxidative properties of freshly synthesized albumin, potentially explaining its limited efficacy.

Conclusions:

  • Albumin infusion has not demonstrated significant clinical benefit across many acute and chronic disease states, with limited exceptions in acute hypovolemia.
  • Further research is needed to determine if freshly synthesized, non-oxidized albumin offers superior clinical advantages.
  • The findings suggest a need to re-evaluate current albumin infusion protocols and explore novel albumin preparations.